Kadimastem Ltd
Kadimastem Ltd (KMSTF) Revenue
Annual & quarterly revenue history · segment & region breakdown
KMSTF · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsKadimastem Ltd trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from $0.00B in FY2024.
Revenue trend
2024 – 2012 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2024-12-31 | $0.00B | +$0.00B | — |
| 2023-12-31 | $0.00B | +$0.00B | — |
| 2022-12-31 | $0.00B | +$0.00B | — |
| 2021-12-31 | $0.00B | +$0.00B | — |
| 2020-12-31 | $0.00B | +$0.00B | — |
| 2019-12-31 | $0.00B | +$0.00B | — |
| 2018-12-31 | $0.00B | -$0.00B | -100.00% |
| 2017-12-31 | $0.00B | -$0.00B | -59.84% |
| 2016-12-31 | $0.00B | +$0.00B | +65.66% |
| 2015-12-31 | $0.00B | +$0.00B | +218.27% |
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Kadimastem Ltd receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Kadimastem Ltd reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in ILS.
Data sourced from Kadimastem Ltd's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
KMSTF revenue · 4 questionsKMSTF's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from $0.00B in FY2024.
▸ Source: FMP · Kadimastem Ltd SEC filings · GAAP · Kadimastem Ltd SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026